Keysight Technologies (KEYS) unveiled new test and measurement products at electronica 2026, focusing on AI infrastructure, communications, power electronics, and cybersecurity. Key introductions included expanded high-power automated test equipment and a compact XR3 oscilloscope, alongside a collaboration with Tower Semiconductor on photonic design tools. These developments reinforce Keysight's strategy to capitalize on AI data center build-outs and high-speed interconnect testing, contributing to its high gross margins and operating margin strength.

The State Street Communication Services Select Sector SPDR ETF (XLC) significantly increased its holdings in Meta Platforms (META) and Alphabet (GOOGL, GOOG) on November 11, with total buys amounting to $84.3 million. META saw the largest addition at $17.8 million, raising its weight to 20.54%, while Alphabet's Class A and C shares also received substantial investments. The fund, focused on large-cap communication services stocks, made no sales and added to 21 existing positions.

MassChallenge, ranked as the No. 2 accelerator in the U.S. by TIME and Statista, is moving its global headquarters to 401 Park Dr. in Boston's Fenway neighborhood. This relocation to an Alexandria Real Estate Equities Megacampus signifies a renewed commitment to fostering entrepreneurship in Boston and aims to strengthen the innovation ecosystem by connecting founders, partners, and investors. The move was supported by Ryan Hurd of Cushman & Wakefield.

Analog Devices (ADI) has seen a resurgence in ETF demand, with major funds showing significant inflows, pushing the stock's year-to-date return to 49.52%. Despite strong momentum, recent volatility suggests a re-evaluation of its AI and energy infrastructure exposure. While analysts deem ADI 13% undervalued with a fair value of $470.72, its P/E ratio of 48x appears expensive compared to the industry average and a suggested fair ratio.

Kathryn A. Moore, SVP of human resources at Motorola Solutions Inc. (NYSE:MSI), sold 1,080.13 shares for $571,825 on November 10, 2026, after exercising stock options. The company recently reported strong third-quarter 2026 earnings, surpassing analyst expectations and raising its full-year outlook.

Intuitive Machines reported a significant 414% year-over-year revenue increase in 3Q 2026, reaching $269.35 million, primarily due to the Lanteris acquisition. The company's net loss attributable to Class A common shareholders narrowed by 40.2%. Key business highlights include a backlog of $1.87 billion and major contract awards, although IM-3 and IM-4 missions were in a loss position.

GSI Technology Inc. director Hong-Po Hsieh was granted a stock option for 16,457 common shares on November 10, 2026. The exercise price is $3.19 per share, and the option expires on November 10, 2036. The option vests fully on August 15, 2027, subject to continued service, or immediately upon a Change in Control before that date.

Credo Technology Group (CRDO) has introduced new Open Compute Project (OCP) approved standards for enhanced telemetry in optical transceivers, a development that aligns with its focus on AI data center connectivity. While these standards are beneficial for Credo's market positioning, the immediate factors influencing its investment case remain its upcoming fiscal Q2 results, expected on December 1, 2026, and its ability to meet revenue and margin guidance amidst AI infrastructure demand. The article suggests that a strong performance in these areas, particularly concerning AI orders and gross margins above 65%, will be crucial in sustaining the current high-risk, execution-heavy investment thesis, which already projects a significant potential upside.

Exide Industries has successfully integrated over 120,000 dealers and 20,000 mechanics onto a unified customer operations platform powered by Salesforce, encompassing sales, service, field operations, and its partner ecosystem across India. This deployment has significantly reduced service response times and improved complaint resolution by over 30 percent. The company now plans to introduce AI agents to further enhance sales, customer support, and various service operations in response to India's evolving mobility landscape.

Guardant Health (GH) has launched five new epigenomic applications for its Guardant360 Liquid test, specifically targeting breast and lung cancers. These tools, powered by the InfinityAI platform, aim to assist oncologists in selecting therapies for patients whose tumors lack clear genomic biomarkers. This expansion is expected to broaden the clinical utility and addressable market for Guardant360 Liquid testing, reinforcing the company's "multi omics data and InfinityAI" growth narrative.